Cargando…
Intravitreal Triamcinolone for Acute Branch Retinal Vein Occlusion: a Randomized Clinical Trial
PURPOSE: To evaluate the therapeutic effect of intravitreal triamcinolone (IVT) injection for recent branch retinal vein occlusion (BRVO). METHODS: In a randomized controlled clinical trial, 30 phakic eyes with recent (less than 10 weeks’ duration) BRVO were assigned to two groups. The treatment gro...
Autores principales: | Ramezani, Alireza, Entezari, Morteza, Moradian, Siamak, Kadkhodaei, Shohreh, Tabatabaei, Homa, Dehsarvi, Babak, Fatehi, Mohammad, Yaseri, Mehdi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ophthalmic Research Center
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3306087/ https://www.ncbi.nlm.nih.gov/pubmed/22454718 |
Ejemplares similares
-
Intravitreal Triamcinolone Reinjection for Refractory Diabetic Macular Edema
por: Ramezani, Alireza, et al.
Publicado: (2006) -
Intravitreal Bevacizumab for Treatment of Refractory Central Serous Choroidoretinopathy
por: Entezari, Morteza, et al.
Publicado: (2012) -
Efficacy of combined intravitreal bevacizumab and triamcinolone for branch retinal vein occlusion
por: Ali, Rasha I, et al.
Publicado: (2014) -
Intravitreal Bevacizumab with or without Triamcinolone for Refractory Diabetic Macular Edema: Long-term Results of a Clinical Trial
por: Shoeibi, Nasser, et al.
Publicado: (2013) -
Changes in Retinal Nerve Fiber Layer Thickness after Two Intravitreal Bevacizumab Injections for Wet Type Age-related Macular Degeneration
por: Entezari, Morteza, et al.
Publicado: (2014)